二甲双胍治疗多囊卵巢综合征抗氯米芬患者12例疗效观察
出处
《浙江预防医学》
2007年第8期63-63,65,共2页
Zhejiang Journal of Preventive Medicine
二级参考文献17
-
1Wu XK,Zhou SY,Sallinen,et al.Ovarian selective resistance to insulin signaling in the polycystic ovary syndrome.Fertil Steril,2003,80(4):954~965.
-
2Karen ER,Evelyn OT,Jeanne VZ,et al.Evidence for competing effects of body mass,hyperinsulinemia,insulin resistance,and androgen on leptin levels among lean,overweight and obese women with polycystic syndrome.Fertil Steril,2002,78(3):479~486.
-
3Macial GA,Soares JM,Alves El,et al.Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.Fertil Steril,2004,81(2):355~360.
-
4Glueck CJ,Goldenberg N,Pranikoff J,et al.Height,weight,and motor-social development during the first 18 months of lifes in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.Hum Reprod,2004,19(6):1323~1330.
-
5Genazzani AD,Battaglia C,Malavasi B,et al.Metformin administration medolates and restore luteining hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.Fetil Steril,2004,81(1):114~119.
-
6Gleuck CJ,Wang P,Fontaine R,et al.Metformin to Restore Normal Menses in Oligo-Amenorrheic Teenage Girls With Polycystic Ovary Syndrome (PCOS).J Adol Health,2001,29(3):160~169.
-
7Kolodziejczyk B,Duleba AJ,Spaczynski RZ,et al.Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.Fertil Steril,2000,73(6):1149~1154.
-
8Laure C,Morin-Papunen,Ilkka V,et al.Endocrine and metabolic effect of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome:a randomized study.J.Clin.Endocrinol.Metab,2000,85(9):3161~3168.
-
9Morin-Papunen L,Vauhkonen I,Koivunen R,et al.Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome:a randomized study.J Clin.Endocrinol.Metab,2003,88(1):148~156.
-
10Elter K,Imir G,Durmusoglu F.Clinical,endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome:a randomized controlled study.Hum Reprod,2002,17(7):1729~1737.
共引文献33
-
1曾玖芝,沈宗姬.青春期多囊卵巢综合征20例临床分析[J].浙江医学,2007,29(2):136-137.
-
2吴坤英,张富青.多囊卵巢综合征妇女妊娠的结局探讨[J].中国误诊学杂志,2006,6(5):857-858. 被引量:1
-
3李永华.二甲双胍治疗克罗米芬抵抗的多囊卵巢综合征56例疗效观察[J].医学信息(西安上半月),2006,19(5):829-831. 被引量:1
-
4梅志雄,覃炜.二甲双胍联合复方醋酸环丙孕酮治疗多囊卵巢综合征40例临床分析[J].南方医科大学学报,2006,26(5):657-658. 被引量:8
-
5李辉,宋小婕.腹腔镜联合药物治疗多囊卵巢综合征50例疗效观察[J].数理医药学杂志,2006,19(3):255-256. 被引量:1
-
6陈晖.口服避孕药联合二甲双胍治疗多囊卵巢综合征临床分析[J].现代医药卫生,2006,22(14):2113-2115. 被引量:4
-
7滕悦秋,郑建华,韩向阳.二甲双胍治疗多囊卵巢综合征的临床效果评价[J].哈尔滨医科大学学报,2007,41(4):405-406. 被引量:1
-
8郭丽春.中西医结合治疗多囊卵巢综合征临床观察[J].广西中医药,2007,30(5):12-13. 被引量:3
-
9崔乐英.达英-35二甲方双胍治疗多囊卵巢综合征[J].医药论坛杂志,2007,28(20):34-35. 被引量:8
-
10李红,程艳.30例多囊卵巢综合征妊娠结局分析[J].云南医药,2008,29(1):38-39. 被引量:4
-
1陆新虹,杨海燕,罗佐杰,马燕.不同胰岛素抵抗状态下多囊卵巢综合征患者内分泌指标与卵巢超声特征的相关性研究[J].中国糖尿病杂志,2015,23(1):40-42. 被引量:53
-
2古岭梅,万晓英,刘彩红.达英-35联合二甲双胍治疗多囊卵巢综合征对性激素、胰岛素抵抗的影响[J].现代医院,2016,16(11):1586-1588. 被引量:8
-
3罗冬梅,杨梅凤.二甲双胍在多囊卵巢综合征不孕症治疗中的作用[J].中国社区医师(医学专业),2013,15(1):153-153. 被引量:4
-
4周维维.罗格列酮联合炔雌醇环丙孕酮治疗多囊卵巢综合征临床疗效观察[J].中国医师进修杂志,2014,37(18):29-31. 被引量:6
-
5祖月娥,李爱林.应用二甲双胍治疗多囊卵巢综合征的临床观察[J].医学临床研究,2007,24(7):1138-1139. 被引量:1
-
6高洁.炔雌醇环丙孕酮联合二甲双胍治疗青春期多囊卵巢综合征疗效观察[J].实用预防医学,2015,22(4):492-494. 被引量:13
-
7张慧英,牛秀敏.妊娠期糖尿病的病因学研究进展[J].中国实用妇科与产科杂志,2007,23(6):452-454. 被引量:11
-
8余进进,陈小平,陆英华,史怀,吴海燕.罗格列酮对多囊卵巢综合症患者胰岛素抵抗状态及血脂、性激素和排卵的影响[J].中国血液流变学杂志,2005,15(2):286-288. 被引量:6
-
9王莉芹,周莉君.二甲双胍治疗多囊卵巢综合征14例疗效分析[J].河北医药,2004,26(11):865-865. 被引量:1
-
10李淑玲,常淑琴,王玖玲,李辉.多囊卵巢综合征中医证型与血清激素水平、胰岛素抵抗的相关性研究[J].上海中医药杂志,2007,41(7):51-52. 被引量:37